:

Yixuan Wang1, Lianru Zhang2, Yanan Du2

  • 1Department of Oncology, Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Jiangsu University, Nanjing, 210009, People's Republic of China.

PubMed
概括

早期复发的乳腺癌患者面临着不良预后和有限的治疗选择. 基因分析揭示了TP53等关键突变,为个性化治疗提供了新的途径.